Ludwig Hammel
Schweinfurt, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Association of an app-based intervention with improvements in mobility, trunk muscle strength and patient-reported disease activity in axial spondyloarthritis: a 24-week pre-post study.
Journal: Therapeutic advances in musculoskeletal disease
Published: March 25, 2026
An app-based nonpharmacological intervention improves patient-reported disease activity, functionality, and quality of life in patients with axial spondyloarthritis: a randomised controlled trial.
Journal: Annals of the rheumatic diseases
Published: November 04, 2025
DOSage of Exercise for chronic low back pain disorders (DOSE): protocol for a systematic review with dose-response network meta-analysis.
Journal: BMJ open sport & exercise medicine
Published: July 05, 2024
COping with Rheumatic Stressors (CORS) questionnaire: validated German translation and cross-cultural adaptation for patients with axSpA.
Journal: Journal of patient-reported outcomes
Published: May 27, 2024
German translation and linguistic validation of the modified short questionnaire to assess health-enhancing physical activity (mSQUASH) for patients with axial spondyloarthritis (axSpA)
Journal: Zeitschrift fur Rheumatologie
Published: March 27, 2024
The exercise-app Axia for axial spondyloarthritis enhances the home-based exercise frequency in axial spondyloarthritis patients - A cross-sectional survey.
Journal: Rheumatology international
Published: March 23, 2024
Nonpharmacological treatment measures, rehabilitation services and membership in patient support groups in axial spondylarthritis (The ATTENTUS axSpA study)
Journal: Zeitschrift fur Rheumatologie
Published: July 21, 2023
Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairment.
Journal: RMD open
Published: August 11, 2022
Apps in rheumatology : Is there a need for an app in therapy for axial spondyloarthritis?
Journal: Zeitschrift fur Rheumatologie
Published: September 01, 2021
Development of quality standards for patients with axial spondyloarthritis for use in Germany
Journal: Zeitschrift fur Rheumatologie
Published: April 25, 2021
Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate.
Journal: BMJ open
Published: October 01, 2020
Last Updated: 09/26/2026